期刊文献+

氯胺酮多次给药对大鼠肝微粒体内细胞色素P450_2B酶的诱导作用 被引量:7

Induction of cytochrome P450_2B in rats' liver microsomes safter repetitive ketamine administration
下载PDF
导出
摘要 目的考察氯胺酮对大鼠肝微粒体内细胞色素P450_2B酶活性的影响。方法以10mg.kg-1.d-1氯胺酮灌胃给予大鼠,连续给药10d。在第11d处死大鼠,以钙离子沉淀法制备肝微粒体。采用Omura和Sato方法测定细胞色素P450含量,采用7-戊氧基试卤灵-O-去烷基反应测定细胞色素P450_2B酶的活性。结果给药组和对照组细胞色素P450的总含量分别是(0.679±0.216)nmol·mg-1和(0.398±0.109)nmol·mg-1,细胞色素P450_2B酶的活性分别是(13.40±3.15)pmol·min-1.mg-1和(7.04±2.09)pmol·min-1.mg-1。结论氯胺酮能够增加大鼠肝微粒中细胞色素P450含量,并能显著诱导细胞色素P450_2B酶的活性。 Objective To investigate the effect of ketamine on cytochrome P450_2B activity in rat liver microsomes. Methods The rats were intragastric administrated with 10 mg·kg^-1·d^-1 ketamine for 10 days. The liver microsomes was prepared by precipitated with calcium ion after the rats were executed on the 11th day. The contents of cytochrome P450 was measured according to the method of Omura and Sato. The O-dealkylation activity of pentoxyresorufin was monitored by fluorescence spectrophotometry, which was employed as the activity of cytochrome P450_2B. Results For ketamine-treated group and saline-control group, the contents of cytochrome P450 were(0. 679±0. 216)nmol · mg^-1 and(0. 398±0. 109)nmol · mg^-1 ,and the activities of cytochrome P450_2B were(13.40±3. 15) pmol·min 1· mg^-1 and(7.04± 2.09) pmol ·min-1 ·mg^-1. Conclusions The cytochrome P450 content in rats' liver microsomes were increased and the cytochrome P450_2B activity was induced significantly after repetitive administration with ketamine.
出处 《成都医学院学报》 CAS 2012年第3期383-385,共3页 Journal of Chengdu Medical College
基金 国家自然科学基金项目(NO:30973369) 成都医学院基金(NO:CYZ08-006)
关键词 氯胺酮 肝微粒体 细胞色素P450酶 细胞色素P450_2B酶 Ketamine Liver microsomes Cytochrome P450 Cytochrome P450_2B
  • 相关文献

参考文献8

  • 1年华,马明华,徐玲玲,陈俊.细胞色素P_(450)酶与药物代谢的研究进展与评价[J].中国医院用药评价与分析,2010,10(11):964-967. 被引量:17
  • 2Copeland J, Dillon P. The health and psycho social consequences of ketamine use[J]. International Journal of Drug Policy,2005,16(2) : 122-131. 被引量:1
  • 3冯波,张慧锋,李妍.氯胺酮的临床应用及滥用危害[J].吉林医药学院学报,2005,26(4):223-224. 被引量:5
  • 4Yanagihara Y, Kariya S, Ohtani M, et al. Involvement of CYP2B6 in the N-demethylation of ketamine in human liver microsomes[J]. Drug Metabolism and Disposition, 2001,29 (6) :887-890. 被引量:1
  • 5Von Bahr C, Groth CG, J ansson H, et al. Drug metabolism in human liver in vitro:establishment of a human liver bank[J]. Clin Pharmacology and Therapeutics,1980,27(6):711-725. 被引量:1
  • 6Dryer RL, Lata GF. Experimental Biochemistry [ M]. New York:Oxford University Press,1989:a46 347. 被引量:1
  • 7Omura T, Sato R. The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature[J]. Journal of Biological Chemistry, 1964,239(7), 2370-2378. 被引量:1
  • 8Donato MT, Gomezlechon MJ, Castell JV. A Microassay for Measuring Cytochrome P450IAI and Cytochrome P450 II B1 Activities in Intact Human and Rat Hepatocytes Cultured on 96-Well Plates [J]. Analytical Biochemistry, 1993, 213 ( 1 ) : 29 33. 被引量:1

二级参考文献24

  • 1沈杰,范乃建.新型毒品氯胺酮(K粉)的毒理作用、滥用趋势及危害[J].云南警官学院学报,2004(3):34-35. 被引量:14
  • 2Falzoi M, Mossa A, Congeddu E, et al. Multiplex genotyping of CYP3A4, CYP3A5, CYP2C9 and CYP2C19 SNPs using MALDI-TOF mass spectrometry [ J ]. Pharmacogenomics, 2010, 11 ( 4 ) : 559. 被引量:1
  • 3Senggunprai L, Kukongviriyapan U, Jetsrisuparb A, et al. Drug metabolizing enzyme CYP1A2 status in pediatric patients with hemoglobin E-beta thalassemia [ J]. J Med Assoc Thai ,2009,92 ( 12 ) : 1675. 被引量:1
  • 4Qiu G, Wang Y, Fu R, et al. Development of primerspecial TaqMan PCR: a novel SNP detection method to detect CYP2C9 3 in South Chinese[ J]. Mol Diagn Ther, 2010,14(2) :123. 被引量:1
  • 5Mo SL,Zhou ZW,Yang LP,et al. New insights into the structural features and functional relevance of human cytochrome P450 2C9. Part I [ J]. Curr Drug Metab, 2009,10(10) :1075. 被引量:1
  • 6Fern~mdez-Santander A, Luna F, Santiago C, et al. CYP2D6 polymorphism screening in a selected population of Spain (La Alpujarra): no effect of geographical isolation[ J1. Ann Hum Biol,2010,37(2) :267. 被引量:1
  • 7Kitada M. Genetic polymorphism of cytochrome P450 enzymes in Asian populations : focus on CYP2D6 [ J ]. Int J Clin Pharmacol Res, 2003,23 ( 1 ) : 31. 被引量:1
  • 8Neafsey P, Ginsberg G, Hattis D, et al. Genetic polymorphism in cytochrome P4so 2D6 (CYP2D6): Population distribution of CYP2D6 activity [ J ]. J Toxicol Environ Health B Crit Rev , 2009 ,12 ( 5 -6 ) :334. 被引量:1
  • 9Li L,Porter TD. Chlorzoxazone hydroxylation in micros-omes and hepatocytes from cytochrome P4so oxidoredu-ctase-null mice[J]. J Biochem Mol Toxicol ,2009 ,23 ( 5 ) :357. 被引量:1
  • 10Liu Y, Jiao J, Zhang C, et al. A simplified method to determine five cytochrome P450 probe drugs by HPLC in a single run [ J ]. Biol Pharm Bull ,2009,32 (4) :717. 被引量:1

共引文献20

同被引文献60

  • 1段晓红,周宏灏.细胞色素氧化酶CYP2C9的诱导机制及研究进展[J].中国药理学通报,2004,20(9):961-965. 被引量:12
  • 2陈霞,何念海.放射测定胎鼠肝脏尿苷二磷酸葡萄糖醛酸转移酶1A1活性[J].中国新生儿科杂志,2006,21(4):204-206. 被引量:1
  • 3Court MH. Isoform-selective probe substrates for in vitro studies of human UDP-glucuronosyltransferases[ J ]. Methods in Enzymology, 2005,400 (2): 104-116. 被引量:1
  • 4Alison MM, Brian B, Michael WH. A Novel Method for the Immunoquantification of UDP-Glucuronosyltransferases in Human Tissue [J]. Drug Metabolism and Disposition, 2011, 39 (12) : 2258-2263. 被引量:1
  • 5Miners JO, Bowalgaha K, Elliot DJ, et al. Characterization of Niflumic Acid as a Selective Inhibitor of Human I.iver Microsomal UDP-Glucuronosyltransferase 1A9: Application to the Reaction Phenotyping of Acetaminophen Glucuronidation[ J ]. Drug Metabolism and Disposition, 2011, 39(4) :644-652. 被引量:1
  • 6Yuji I, Hiroki K, Kousuke K. Alteration of the Function of the UDP-Glucuronosyltransferase 1A Subfamily by Cytochrome P450 3A4: Different Suseeptibility for UGT Isoforms and UGT1A1/7 Variants[J]. Drug Metabolism and Disposition,2014, 42(2): 229-238. 被引量:1
  • 7Tuomainen P,Reenih I,Mfinnist PT. Validation of assay of catechol- O-methyltransferase activity in human erythrocytes [ J ]. J Phann Biomed Anal,1996,14(5) :515-523. 被引量:1
  • 8Masuda M, Tsunoda M, Imai K. High-performance liquid chromato- graphy-fluorescent assay of catechol-O-methyltransferasc activity in rat brain[J]. Anal Bioanal Chem,2003,376(6) :1069-1073. 被引量:1
  • 9Maurer HH, Bickeboeller-Friedrich J, Kraemer T. Gas chromatogra- phic-mass spectrometric procedures for determination of the unstable catecholic metabolites in human and rat liver preparations after COMT catalyzed in statu nascencli derivatization using S- adenosylmethionine[J]. J Chromatogr B Biomed Sci Appl,2000,739(2) :325-335. 被引量:1
  • 10CUPP M J,TRACY T S.Cytochrome P450:new nomenclature and clinical implications[J].Am Fam Physician,1998,57(1):107-116. 被引量:1

引证文献7

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部